A MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, 28-DAY STUDY OF D

本子项目是利用由NIH/NCRR资助的中心赠款提供的资源的众多研究子项目之一。子项目和研究者（PI）可能已经从另一个NIH来源获得了主要资金，因此可以在其他CRISP条目中表示。列出的机构是中心的，不一定是研究者的机构。本研究的目的是评估两种剂量水平的INS37217吸入溶液与安慰剂的安全性和耐受性，这些安慰剂每天给药三次，持续28天，用于CF肺病患者，并获得疗效的初步证据。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The objectives of this study are to evaluate the safety and tolerability of two dose levels of INS37217 Inhalation Solution compared to placebo administered three times daily over 28 days in patients with CF lung disease and to gain preliminary evidence of efficacy.